We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Acoustic Device Designed to Separate Tumor Cells from Blood Cells Could Help Assess Cancer’s Spread

By LabMedica International staff writers
Posted on 23 Sep 2014
Print article
Image: Microfluidic device uses sound waves to sort tumor from white-blood cells as they flow through the channel from left to right (IDT [interdigital transducers] are sound source) (Photo courtesy of Ding X, et al).
Image: Microfluidic device uses sound waves to sort tumor from white-blood cells as they flow through the channel from left to right (IDT [interdigital transducers] are sound source) (Photo courtesy of Ding X, et al).
Researchers have devised a new way to separate cells by exposing them to sound waves as they flow through a tiny channel. Their device, approximately the size of a dime, could be used to detect the extremely rare tumor cells that circulate in cancer patients’ blood, helping clinicians predict whether a tumor is going to metastasize.

Separating cells with sound offers a milder option to existing cell-sorting technologies, which require tagging the cells with chemicals or exposing them to stronger mechanical forces that may damage them. “Acoustic pressure is very mild and much smaller in terms of forces and disturbance to the cell. This is a most gentle way to separate cells, and there’s no artificial labeling necessary,” said Dr. Ming Dao, a lead research scientist in Massachusetts Institute of Technology’s (MIT; Cambridge, MA, USA) department of materials and engineering, and one of the senior authors of the paper, which was published in September 2014 in the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS).

Subra Suresh, president of Carnegie Mellon University (Pittsburgh, PA, USA), a professor of engineering emeritus, and a former dean of engineering at MIT, and Tony Jun Huang, a professor of engineering science and mechanics at Pennsylvania State University (Penn State; University Park, USA), are also senior authors of the article. The researchers have filed for a patent on the device; the technology of which they have demonstrated can be used to separate rare circulating cancer cells from white blood cells.

To sort cells using sound waves, scientists have previously built microfluidic devices with two acoustic transducers, which produce sound waves on either side of a microchannel. When the two waves meet, they combine to form a standing wave (a wave that remains in constant position). This wave generates a pressure node (line of low pressure) running parallel to the direction of cell flow. Cells that encounter this node are moved to the side of the channel; the distance of cell movement depends on their size and other properties such as compressibility.

However, these existing devices are inefficient: Because there is only one pressure node, cells can be pushed aside only short distances. The new device overcomes that obstacle by tilting the sound waves so they run across the microchannel at an angle: meaning that each cell encounters several pressure nodes as it flows through the channel. Each time it encounters a node, the pressure guides the cell a little further off center, making it simpler to capture cells of different sizes by the time they reach the end of the channel.

This simple modification drastically increases the efficiency of such devices, according to Taher Saif, a professor of mechanical science and engineering at the University of Illinois at Urbana-Champaign (USA). “That is just enough to make cells of different sizes and properties separate from each other without causing any damage or harm to them,” said Prof. Saif, who was not involved in this work.

In this study, the researchers first assessed the system with plastic beads, finding that it could separate beads with diameters of 9.9 and 7.3 micrometers with approximately 97% accuracy. They also devised a computer simulation that can predict a cell’s trajectory through the channel based on its size, density, and compressibility, as well as the angle of the sound waves, allowing them to tailor the device to separate different types of cells.

To evaluate whether the device could be useful for detecting circulating tumor cells, the researchers tried to separate breast cancer cells known as MCF-7 cells from white blood cells. These two cell types differ in size (20 micrometers in diameter for MCF-7 and 12 micrometers for white blood cells), as well as density and compressibility. The device successfully recovered about 71% of the cancer cells; the researchers plan to test it with blood samples from cancer patients to see how well it can detect circulating tumor cells in clinical settings. Such cells are very scarce; a 1-mL sample of blood may contain only a few tumor cells.

“If you can detect these rare circulating tumor cells, it’s a good way to study cancer biology and diagnose whether the primary cancer has moved to a new site to generate metastatic tumors,” Dr. Dao stated.

“This method is a step forward for detection of circulating tumor cells in the body. It has the potential to offer a safe and effective new tool for cancer researchers, clinicians, and patients,” Dr. Suresh concluded.

Related Links:

Massachusetts Institute of Technology
Carnegie Mellon University
Pennsylvania State University


Gold Member
Blood Gas Analyzer
GEM Premier 7000 with iQM3
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Hepato Fibrosis Assays
Hepato Fibrosis Assays
New
Progesterone Serum Assay
Progesterone ELISA Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: Schematic overview of maternal biomarker discovery using cell-free RNA during pregnancy (Photo courtesy of Circulation Research (2024). DOI: 10.1161/CIRCRESAHA.124.325024)

Maternal Blood Test Identifies Congenital Heart Diseases in Fetus

Each year, around 1,000 children are born with a single ventricle heart defect (SVHD), a condition where one of the heart's lower chambers is underdeveloped, too small, or missing a valve.... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Microbiology

view channel
Image: The InfectoSynovia test has the potential to revolutionize the diagnosis of periprosthetic joint infection (Photo courtesy of 123RF)

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Periprosthetic joint infection (PJI) represents a significant global issue that is worsening as the number of joint replacements increases due to aging populations. In the United States alone, the anticipated... Read more

Pathology

view channel
Image

AI-Based Method Shows Promise for Pathological Diagnosis of Hereditary Kidney Diseases

Alport syndrome is a hereditary kidney disorder characterized by kidney dysfunction, sensorineural hearing loss, and ocular abnormalities. Early in the disease, patients experience hematuria, which is... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.